Cargando…

Cooling down VITT with IVIG

Detalles Bibliográficos
Autor principal:	Lentz, Steven R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2021
Materias:	Blood Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8444694/ https://www.ncbi.nlm.nih.gov/pubmed/34529019 http://dx.doi.org/10.1182/blood.2021012819

Ejemplares similares

Understanding VITT(ual) reality
por: Rauova, Lubica, et al.
Publicado: (2021)

VITT(al) insights into vaccine-related clots
por: Strich, Jeffrey R., et al.
Publicado: (2021)

Antiplatelet drugs block platelet activation by VITT patient serum
por: Smith, Christopher W., et al.
Publicado: (2021)

Monoclonal and oligoclonal anti-platelet factor 4 antibodies mediate VITT
por: Kanack, Adam J., et al.
Publicado: (2022)

Role of Anticoagulation and IVIG in Treatment of Vaccine-Induced Thrombotic Thrombocytopenia (VITT)
por: Tariq, Anosha, et al.
Publicado: (2022)

Vaccine‐induced Immune Thrombocytopenia and Thrombosis (VITT)
por: Makris, Michael, et al.
Publicado: (2021)

The race to stymie BTK: zanu zings
por: Kapoor, Prashant, et al.
Publicado: (2020)

Another front in COVID-19’s perfect storm
por: Jobe, Shawn M., et al.
Publicado: (2021)

Vaccination against COVID-19: a challenge in CLL
por: Eichhorst, Barbara
Publicado: (2021)

Thrombosis with COVID-19: kids get it too
por: Takemoto, Cliff
Publicado: (2021)

Neutrophils clear sterile inflammatory debris
por: Yost, Christian Con
Publicado: (2021)

Boosting BNT162b2 vaccine efficacy in CLL
por: Bhat, Seema A., et al.
Publicado: (2022)

Danger ahead: COVID-19 infections after vaccination
por: Greenberger, Lee M., et al.
Publicado: (2022)

Vaccinations and ITP: keep on track(ing)
por: Bakchoul, Tamam, et al.
Publicado: (2022)

A tale of two alleles: TP53 and transformation in MPNs
por: Brierley, Charlotte, et al.
Publicado: (2022)

Why B(-)other? About the gap of unknowns in ALL
por: Fioretos, Thoas
Publicado: (2022)

Tet2 helps blood cells balance in air
por: Chute, John P.
Publicado: (2022)

CD7 CAR: sword and shield
por: Velasquez, M. Paulina, et al.
Publicado: (2022)

Buckling up against COVID-19 after CAR T-cell therapy
por: Auletta, Jeffery J.
Publicado: (2022)

CLL and COVID-19: light at the end of the tunnel?
por: Scarfò, Lydia, et al.
Publicado: (2022)

Platelets get particular
por: Rauova, Lubica, et al.
Publicado: (2022)

Epidemiology of VITT
por: Pai, Menaka
Publicado: (2022)

COVID-19: The Second Wave is not due to Cooling-down in Autumn
por: Langel, Walter
Publicado: (2021)

Longitudinal Aspects of VITT
por: Schönborn, Linda, et al.
Publicado: (2022)

Heparin or nonheparin anticoagulants for VITT
por: Arnold, Donald M.
Publicado: (2022)

Whole blood donor behavior and availability after deferral: Consequences of a new ferritin monitoring policy
por: Spekman, Marloes L.C., et al.
Publicado: (2020)

Barriers to blood donation on social media: An analysis of Facebook and Twitter posts
por: Ramondt, Steven, et al.
Publicado: (2020)

New blood donors in times of crisis: Increased donation willingness, particularly among people at high risk for attracting SARS‐CoV‐2
por: Spekman, Marloes L. C., et al.
Publicado: (2021)

COVID-19 vaccin et VITT
por: Pernod, G.
Publicado: (2021)

COVID-19 and VITT: same or different?
por: Arepally, Gowthami M.
Publicado: (2021)

ViTT: Vision Transformer Tracker
por: Zhu, Xiaoning, et al.
Publicado: (2021)

Second-dose VITT: rare but real
por: Pavord, Sue, et al.
Publicado: (2022)

Long VITT: A case report
por: Roberge, Guillaume, et al.
Publicado: (2023)

What would it take to convince you to donate? A survey study of the relationship between motivators, barriers, and payment for whole blood, plasma, and platelet donation
por: France, Christopher R., et al.
Publicado: (2022)

Personalized collection of plasma from healthy donors: A randomized controlled trial of a novel technology‐enabled nomogram
por: Hartmann, Jan, et al.
Publicado: (2021)

Communicating the move to individualized donor selection policy: Framing messages focused on recipients and safety
por: Ferguson, Eamonn, et al.
Publicado: (2022)

Blood donation motivators and barriers reported by young, first‐time whole blood donors: Examining the association of reported motivators and barriers with subsequent donation behavior and potential sex, race, and ethnic group differences
por: France, Christopher R., et al.
Publicado: (2022)

Vaccination-induced thrombocytopenia and thrombosis (VITT) and pre-VITT: Do not miss (or misdiagnose) the new member of the thrombotic thrombocytopenias family
por: Noyé, Mickaël, et al.
Publicado: (2022)

Detection, characterization, and enrollment of donors of Ebola convalescent plasma in Sierra Leone
por: Tedder, Richard S., et al.
Publicado: (2018)

Assessment of serological assays for identifying high titer convalescent plasma
por: Farnsworth, Christopher W., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o65ejsjr5lkrfhs4hhcbf40mq3